ScoreWhy is Jamjoom Pharmaceuticals Factory Co. ?
1
With ROE of 26.14%, it has a very attractive valuation with a 6.71 Price to Book Value
- Over the past year, while the stock has generated a return of -22.74%, its profits have risen by 23% ; the PEG ratio of the company is 1.1
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Jamjoom Pharmaceuticals Factory Co. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Jamjoom Pharmaceuticals Factory Co. for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Jamjoom Pharmaceuticals Factory Co.
-100.0%
-0.20
29.64%
Saudi Arabia All Share TASI
-11.13%
-0.71
15.65%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.44%
EBIT Growth (5y)
16.61%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
0.85
Tax Ratio
5.60%
Dividend Payout Ratio
60.08%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
26.93%
ROE (avg)
21.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
6.71
EV to EBIT
25.22
EV to EBITDA
23.07
EV to Capital Employed
7.41
EV to Sales
7.70
PEG Ratio
1.12
Dividend Yield
NA
ROCE (Latest)
29.37%
ROE (Latest)
26.14%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
ROCE(HY)
Highest at 28.89%
RAW MATERIAL COST(Y)
Fallen by -1.56% (YoY
NET PROFIT(9M)
Higher at SAR 395.87 MM
-4What is not working for the Company
INTEREST(HY)
At SAR 0.66 MM has Grown at 62.84%
INTEREST COVERAGE RATIO(Q)
Lowest at 33,835.52
Here's what is working for Jamjoom Pharmaceuticals Factory Co.
Net Profit
Higher at SAR 395.87 MM
than preceding 12 month period ended Sep 2025MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Profit (SAR MM)
Raw Material Cost
Fallen by -1.56% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at SAR 11.44 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (SAR MM)
Here's what is not working for Jamjoom Pharmaceuticals Factory Co.
Interest Coverage Ratio
Lowest at 33,835.52
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest
At SAR 0.66 MM has Grown at 62.84%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (SAR MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
